Zenas Biopharma Inc. has announced the approval of its Amended and Restated Short-Term Incentive Plan, effective January 1, 2026. The plan provides regular full- and part-time employees with the opportunity to earn annual discretionary cash bonuses based on company performance and individual achievement of specified goals. The plan is administered by the Board of Directors for executives and by the CEO and executive leadership team for other employees. All payouts are subject to review and approval by the administrators, and payments will be made no later than March 15 following the end of each calendar year. Employees must be employed through the payment date to receive any award. The company retains the right to amend or discontinue the plan at any time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-015314), on February 13, 2026, and is solely responsible for the information contained therein.